Document is current

Article History

Received: 15 February 2021

Revised: 24 May 2021

Accepted: 9 June 2021

First Online: 16 June 2021

Compliance with ethical standards

:

: SA has received speakers’ fees from AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Janssen, Takeda, and UCB Japan. NT has received research support and/or speakers’ fees from AbbVie, Bristol-Myers Squibb, Chugai, Eisai, Mitsubishi Tanabe, Asahi Kasei, Astellas, Pfizer, Janssen, Daiichi-Sankyo, Takeda, Eli Lilly, Novartis, and UCB Japan. TN has received a speakers’ fee from Eli Lilly. YH has received speakers’ fees from AbbVie, Asahi Kasei, Astellas, Ayumi, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Janssen, Mitsubishi Tanabe, Nippon Kayaku, Pfizer, and UCB Japan. YY has received a speakers’ fee from Asahi Kasei. MS has received speakers’ fees from Bristol-Myers Squibb, Eisai, and Asahi Kasei. NI has received grant/research support, consulting fees, and/or speakers’ fees from AbbVie, Asahi Kasei, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Kaken, Mitsubishi Tanabe, Ono, Otsuka, Pfizer, Taisho Toyama, and Takeda. SI has received grant/research support from Zimmer Biomet. TK has received grant/research support and/or speakers’ fees from AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sanksyo, Eli Lilly, Janssen, Mitsubishi Tanabe, Novartis, Pfizer, and Takeda. All other authors declare no conflicts of interest.

: This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (2011–1164) and complied with the principles set forth in the Declaration of Helsinki.

: Written informed consent was obtained from all participants.